Wir freuen uns, Ihnen die beliebtesten Generika zu bieten, die die teure Marke Medikamente ersetzen. Wir sind sicher, dass diese hochwertigen Generika, die hohen Standards, die Sie von uns erwarten heute und in Zukunft gerecht zu werden.
Phase III abgeschlossen: GSK plant Einreichung von Relovair gegen COPD - Chemiereport
ChemiereportPhase III abgeschlossen: GSK plant Einreichung von Relovair gegen COPDChemiereportIn einer 12-wöchigen Überlegenheitsstudie, einmal täglich FF/VI 100/25 µg verglichen mit „Seretide“ (Wirkstoffe Fluticason Propionate/Salmeterol) 500/50µg zweimal täglich, verfehlte FF/VI den vordefinierten Grenzwert für Überlegenheit im 24 Stunden .
Orion continues development of inhalable budesonide-formoterol combined ... - Reuters (press release)
Orion continues development of inhalable budesonide-formoterol combined .
Pharma sales flat but GSK pleased with R&D progress - Pharma Times
Sky NewsPharma sales flat but GSK pleased with R&D progressPharma TimesAdvair/Seretide (salmeterol and fluticasone) for asthma and chronic obstructive pulmonary disease, was again GSK's top-seller, up 2% to £1.
Combined asthma medication therapy shown to reduce attacks - Medical Xpress
Combined asthma medication therapy shown to reduce attacksMedical XpressThe safety of LABAs by themselves as a therapy were called into question after a high number of deaths and serious asthma attacks were reported in the Salmeterol Multicenter Asthma Research Trial, forcing it to be abruptly stopped in 2003.
Woman's suit blames Advair for son's near fatal asthma attack - Southeast Texas Record
Southeast Texas RecordWoman's suit blames Advair for son's near fatal asthma attackSoutheast Texas RecordCourt papers explain that Advair contains fluticasone, a steroid, and salmeterol, an agonist, and was first approved by the Food and Drug Administration in 2000.